Straits Times Index
3,404.47 -6.34 (-0.19%) S&P 500
5,574.19 +7.00 (+0.13%) Dow
39,526.80 +150.93 (+0.38%) Nasdaq
18,382.81 +30.05 (+0.16%) Bitcoin USD
56,326.44 -589.32 (-1.04%) CMC Crypto 200
1,201.36 +35.25 (+3.02%)
Fortis Healthcare Limited (FORTIS.BO)
| Previous close | 461.95 |
| Open | 468.95 |
| Bid | 0.00 x 0 |
| Ask | 455.85 x 0 |
| Day's range | 453.95 - 471.35 |
| 52-week range | 308.25 - 509.85 |
| Volume | |
| Avg. volume | 105,746 |
| Market cap | 344.148B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 57.34 |
| EPS (TTM) | 7.95 |
| Earnings date | 02 Aug 2024 - 06 Aug 2024 |
| Forward dividend & yield | 1.00 (0.22%) |
| Ex-dividend date | 20 Jul 2023 |
| 1y target est | 180.60 |
The Edge SingaporeIHH Healthcare’s indirect subsidiary to withdraw IPO plans
As at 3.33pm, shares in IHH are trading flat at $1.74.
- Reuters SG
India's big hospital chains think small to expand in booming market
India's prominent hospital chains are shifting their focus to smaller centres and facilities as they chase growth in the booming healthcare market while coping with higher real estate costs and a dearth of land space in its cities. Though healthcare facilities are still in short supply in most parts of India, and especially so in its towns and smaller cities, patients in the world's most populous nation are showing a greater preference for specialised-but-accessible amenities in the post-COVID pandemic era. That trend is expected to form the bedrock of demand in the Indian healthcare market, which, according to forecasts by global consulting firms Boston Consulting Group and B Capital, is expected to grow near three-fold over eight years to $458 billion in 2030.
ReutersIHH Healthcare unit sues Japan's Daiichi Sankyo over Fortis deal
On Oct, 16, Northern TK Venture filed a claim against the Japanese pharmaceuticals manufacturer stating it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018. IHH Healthcare in December 2018 halted its open offer to buy an additional 26% stake in Fortis after a court ruling ordered status quo to be maintained after Daiichi filed a contempt plea against Fortis founders, according to media reports. "The claims filed by NTK against Daiichi Sankyo are tort claims premised on the latter's unlawful interference with NTK’s trade or business, conspiracy of Daiichi Sankyo and other persons, malicious falsehood and defamation under the applicable substantive laws," IHH Healthcare said on Tuesday.
